Article Date

PM Group’s Basel office recently held an Expert Forum on the Eudralex - Annex 1 & Annex 2 requirements. We were delighted to be joined by clients from multi-national pharmaceutical companies based in Switzerland including, Biogen, Janssen, Incyte and Lonza.

During the event, multi-disciplinary guidance and advice was provided by PM Group’s subject matter experts:- Alan Kelly, fill finish biopharmaceutical processes specialist; Alfred Penfold, expert in cGMPs/regulatory compliance and serialisation (Track & Trace); and Jordaan Kemp, Director of Architecture and specialist in laboratory design and the project management of largescale, life science projects.

The objective of PM Group’s new Expert Forum is to create a technical community to discuss in an open environment, key areas for design development and support around regulatory processes. In the future, we look forward to hosting sessions on key topics in the fields of architecture and engineering.


Learn more about Eudralex Annex 1 and 2:


Pictured above L-R: Andrea Brunetti, Operations Director, WE; Angela D’Urso, Head of Engineering, Switzerland; Sacha Marchal, Principal Architect; Fergal O'Neill, Operations Manager, Switzerland.

Looking for further information or help with your project?

Contact our Pharma expert team
Contact our Pharma expert team

Contact our Pharma expert team